HALO logo
halo search icon
MannKind Corporation
MannKind Corporation
MNKD · NAS

MannKind Corporation

US$3.25

Price Arrow0.29 (9.80%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MannKind Corporation Overview

MNKD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About MNKD

icon

Telephone

1.818.661.5000

icon

Address

1 Casper Street, Danbury, CT 06810

Description

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

MNKD Price Chart

Key Stats

Market Cap

US$914.49M

PE

303.20

EV/EBITDA

30.2

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.23 - 6.51

Trade Value (12mth)

US$4,832,734.00

1 week

-4.21%

1 month

9.63%

YTD

-47.14%

1 year

-29.02%

All time high

121.55

Key Fundamentals

EPS 3 yr Growth

-105.60%

EBITDA Margin

19.60%

Operating Cashflow

$18m

Free Cash Flow Return

8.30%

ROIC

2.70%

Interest Coverage

1.80

Quick Ratio

1.50

Other Data

Shares Outstanding (Fully Diluted)

308m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MNKD Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
27 February 26
27 February 26

MNKD Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.040.10.02locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.040.10.02locklocklock
Growth
%locklocklocklock86.9324.8-80.9locklocklock
PE
XlocklocklocklockN/A66.2303.2locklocklock
EV/EBITDA
XlocklocklocklockN/A22.830.2locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of MannKind Corporation (MNKD:NAS)?
Halo FAQ
The current share price of MannKind Corporation (MNKD:NAS) is USD$3.25.
What is the 52-week high share price for MannKind Corporation (MNKD:NAS)?
Halo FAQ
The 52-week high share price for MannKind Corporation (MNKD:NAS) is USD$6.51.
What is the 52-week low share price for MannKind Corporation (MNKD:NAS)?
Halo FAQ
The 52-week low share price for MannKind Corporation (MNKD:NAS) is USD$2.23.
What is the dividend yield for MannKind Corporation (MNKD:NAS)?
Halo FAQ
MannKind Corporation (MNKD:NAS) does not pay a dividend.
What was MannKind Corporation (MNKD:NAS) last dividend payment?
Halo FAQ
MannKind Corporation (MNKD:NAS) does not pay a dividend.
What is the franking level for MannKind Corporation (MNKD:NAS)?
Halo FAQ
MannKind Corporation (MNKD:NAS) has a franking level of 0.00%.
In which sector is MannKind Corporation (MNKD:NAS) classified?
Halo FAQ
MannKind Corporation (MNKD:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for MannKind Corporation (MNKD:NAS)?
Halo FAQ
The current P/E ratio for MannKind Corporation (MNKD:NAS) is 303.20.

See beyond the curve.

One solution for research, investing and portfolio management.